Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
Europe
0
Australia
0
South Africa
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Codinovo
2. Dicodid
3. Dihydrocodeinone
4. Hycodan
5. Hycon
6. Hydrocodeinonebitartrate
7. Hydrocodon
8. Hydrocodone
9. Hydrocodone Tartrate (1:1), Hydrate (2:5)
10. Hydrocon
11. Robidone
1. (4r,4ar,7ar,12bs)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;2,3-dihydroxybutanedioic Acid
2. .codon
3. Schembl154972
4. Chembl2062267
1. Hydrocone
2. Multacodin
3. Hydrocodone
Molecular Weight | 449.4 g/mol |
---|---|
Molecular Formula | C22H27NO9 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 4 |
Exact Mass | 449.16858144 g/mol |
Monoisotopic Mass | 449.16858144 g/mol |
Topological Polar Surface Area | 154 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 642 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-23
Pay. Date : 2013-04-09
DMF Number : 19848
Submission : 2006-10-03
Status : Active
Type : II
NDC Package Code : 49812-0132
Start Marketing Date : 1996-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-08
Pay. Date : 2012-11-23
DMF Number : 21158
Submission : 2007-12-18
Status : Active
Type : II
NDC Package Code : 51634-0014
Start Marketing Date : 1987-07-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-31
Pay. Date : 2014-03-20
DMF Number : 23681
Submission : 2010-03-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-11
Pay. Date : 2012-11-27
DMF Number : 4884
Submission : 1983-03-15
Status : Active
Type : II
NDC Package Code : 0406-1559
Start Marketing Date : 2011-12-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2022-05-25
Registration Number : 20220525-211-J-1305
Manufacturer Name : SpecGx LLC
Manufacturer Address : 3600 North 2nd Street, St. Louis, MO 63147, USA
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17285
Submission : 2004-03-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24846
Submission : 2011-09-30
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-23
Pay. Date : 2013-11-25
DMF Number : 25961
Submission : 2013-10-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-10-20
Pay. Date : 2014-10-14
DMF Number : 19460
Submission : 2006-05-26
Status : Active
Type : II
NDC Package Code : 0792-0543
Start Marketing Date : 2006-05-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
26
PharmaCompass offers a list of Hydrocodone Bitartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydrocodone Bitartrate manufacturer or Hydrocodone Bitartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydrocodone Bitartrate manufacturer or Hydrocodone Bitartrate supplier.
PharmaCompass also assists you with knowing the Hydrocodone Bitartrate API Price utilized in the formulation of products. Hydrocodone Bitartrate API Price is not always fixed or binding as the Hydrocodone Bitartrate Price is obtained through a variety of data sources. The Hydrocodone Bitartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CODAMINE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CODAMINE, including repackagers and relabelers. The FDA regulates CODAMINE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CODAMINE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CODAMINE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CODAMINE supplier is an individual or a company that provides CODAMINE active pharmaceutical ingredient (API) or CODAMINE finished formulations upon request. The CODAMINE suppliers may include CODAMINE API manufacturers, exporters, distributors and traders.
click here to find a list of CODAMINE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CODAMINE DMF (Drug Master File) is a document detailing the whole manufacturing process of CODAMINE active pharmaceutical ingredient (API) in detail. Different forms of CODAMINE DMFs exist exist since differing nations have different regulations, such as CODAMINE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CODAMINE DMF submitted to regulatory agencies in the US is known as a USDMF. CODAMINE USDMF includes data on CODAMINE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CODAMINE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CODAMINE suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CODAMINE Drug Master File in Korea (CODAMINE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CODAMINE. The MFDS reviews the CODAMINE KDMF as part of the drug registration process and uses the information provided in the CODAMINE KDMF to evaluate the safety and efficacy of the drug.
After submitting a CODAMINE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CODAMINE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CODAMINE suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CODAMINE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CODAMINE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CODAMINE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CODAMINE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CODAMINE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CODAMINE suppliers with NDC on PharmaCompass.
CODAMINE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CODAMINE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CODAMINE GMP manufacturer or CODAMINE GMP API supplier for your needs.
A CODAMINE CoA (Certificate of Analysis) is a formal document that attests to CODAMINE's compliance with CODAMINE specifications and serves as a tool for batch-level quality control.
CODAMINE CoA mostly includes findings from lab analyses of a specific batch. For each CODAMINE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CODAMINE may be tested according to a variety of international standards, such as European Pharmacopoeia (CODAMINE EP), CODAMINE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CODAMINE USP).